Go Mediaction

Main Menu

  • Home
  • Medical field
  • Prescription drugs
  • Drug discovery
  • Medical diagnosis

Go Mediaction

Header Banner

Go Mediaction

  • Home
  • Medical field
  • Prescription drugs
  • Drug discovery
  • Medical diagnosis
Prescription drugs
Home›Prescription drugs›Many seniors are ready to reduce their list of prescription drugs, survey reveals –

Many seniors are ready to reduce their list of prescription drugs, survey reveals –

By Deborah A. Gray
June 7, 2022
0
0

According to a new survey, many older people say they are motivated to cut back on their prescription drugs to avoid future side effects – if their doctors suggest it.

Polypharmacy is common among the elderly, with 36% of people aged 65 and over taking five or more medications simultaneously. Fully 1 in 5 of these medications taken may be inappropriate, researchers reported Monday in the Journal of the American Geriatrics Society.

However, efforts to reduce unnecessary prescribing in the United States have been “suboptimal”, the researchers said. The new survey aimed to determine how older patients’ health priorities influence their willingness to work with their doctors to stop current medications.

The survey interviewed more than 800 seniors between March and April 2020. Most respondents said they were willing to deprescribe if their doctors recommended it. Also, more respondents (60%) said they would stop preventative medications compared to symptom-relieving medications (33%), but many were willing to stop both, the investigators reported.

Fewer drugs a priority

At least a third of them prioritized taking fewer medications despite the risk of occasional symptoms or a shorter lifespan, they found. And these respondents were often the ones who were willing to stop both classes of drugs.

In contrast, respondents who prioritized feeling better now were less likely to stop their medications for symptom relief. Notably, study participants who had currently or previously taken statins were less willing to stop preventer medications. Almost 60% had taken a statin and 15% had used a prescription sedative-hypnotic.

Patients ready to talk

The findings suggest an opportunity for clinicians to talk to patients about deprescribing, the authors wrote. Seniors’ health priorities are closely tied to their willingness to deprescribe potentially unnecessary medications, they explained.

“Clinicians must also be able to recognize and act on signals that patients might be interested in deprescribing, such as comments about the inconveniences, potential adverse effects, or costs of taking the medication,” wrote they noted.

Related Articles:

AMDA aims for a 25% reduction in drugs during the deprescribing campaign by sharing data

Nursing home residents more open to deprescribing when suggested by doctor

Categories

  • Drug discovery
  • Medical diagnosis
  • Medical field
  • Prescription drugs

Recent Posts

  • Drug Discovery Informatics Market growth opportunities to be exploited
  • key vendors, trends, analysis, segmentation, forecast to 2029 – Designer Women
  • Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report 2022 – ResearchAndMarkets.com
  • PROBE AND ACT ON PRESCRIPTION DRUGS ABUSE
  • Prescription Drug Consumption Market Size, Share and Forecast to 2028 | Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD) – Designer Women

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • November 2020
  • September 2020
  • May 2020
  • March 2020
  • September 2019
  • May 2019
  • August 2018
  • December 2013
  • Privacy Policy
  • Terms and Conditions